Back to Search
PAUL CONNORS, M.D.
M.D.
Anesthesiology Physician
NPI: 1811335953IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
036.140878(IL)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Class of 2013
Research & Publications (16)
Synthesis and structure-activity relationships of uracil derived human GnRH receptor antagonists: (R)-3-[2-(2-amino)phenethyl]-1-(2,6-difluorobenzyl)-6-methyluracils containing a substituted thiophene or thiazole at C-5.
PMID 15341961·Bioorg Med Chem Lett·2004
8-other
3-(2-aminoalkyl)-1-(2,6-difluorobenzyl)-5- (2-fluoro-3-methoxyphenyl)-6-methyl-uracils as orally bioavailable antagonists of the human gonadotropin releasing hormone receptor.
PMID 15214774·J Med Chem·2004
7-preclinical
Synthesis and structure-activity relationships of 1-arylmethyl-5-aryl-6-methyluracils as potent gonadotropin-releasing hormone receptor antagonists.
PMID 14971906·J Med Chem·2004
7-preclinical
Using a visual plate waste study to monitor menu performance.
PMID 14702591·J Am Diet Assoc·2004
8-other
Synthesis and structure-activity relationships of 1-arylmethyl-3-(1-methyl-2-amino)ethyl-5-aryl-6-methyluracils as antagonists of the human GnRH Receptor.
PMID 12951117·Bioorg Med Chem Lett·2003
8-other
Quinoline-carboxylic acids are potent inhibitors that inhibit the binding of insulin-like growth factor (IGF) to IGF-binding proteins.
PMID 12749901·Bioorg Med Chem Lett·2003
8-other
6,7-dihydroxyisoquinoline-3-carboxylic acids are potent inhibitors on the binding of insulin-like growth factor (IGF) to IGF-binding proteins: optimization of the 1-position benzoyl side chain.
PMID 12749900·Bioorg Med Chem Lett·2003
8-other
Identification of 1-arylmethyl-3- (2-aminoethyl)-5-aryluracil as novel gonadotropin-releasing hormone receptor antagonists.
PMID 12747774·J Med Chem·2003
7-preclinical
Design and structure-activity relationships of 2-alkyl-3-aminomethyl-6-(3-methoxyphenyl)-7-methyl-8-(2-fluorobenzyl)imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonists.
PMID 12699396·J Med Chem·2003
8-other
A novel synthesis of 7-aryl-8-fluoro-pyrrolo[1,2-a]pyrimid-4-ones as potent, stable GnRH receptor antagonists.
PMID 12419391·Bioorg Med Chem Lett·2002
4-observational
Design, synthesis and structure-activity relationships of novel imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonists.
PMID 12127533·Bioorg Med Chem Lett·2002
7-preclinical
Synthesis and initial structure-activity relationships of a novel series of imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonists.
PMID 12127532·Bioorg Med Chem Lett·2002
8-other
A novel synthesis of 2-arylpyrrolo[1,2-a]pyrimid-7-ones and their structure-activity relationships as potent GnRH receptor antagonists.
PMID 11814807·Bioorg Med Chem Lett·2002
7-preclinical
Initial structure-activity relationship studies of a novel series of pyrrolo[1,2-a]pyrimid-7-ones as GnRH receptor antagonists.
PMID 11814806·Bioorg Med Chem Lett·2002
7-preclinical
Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers.
PMID 10969293·Anesthesiology·2000
4-observational
Pediatric evaluation of the bispectral index (BIS) monitor and correlation of BIS with end-tidal sevoflurane concentration in infants and children.
PMID 10735791·Anesth Analg·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 251 E HURON ST
CHICAGO, IL 60611 - Phone
- (312) 926-2000
Quick Facts
- NPI
- 1811335953
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 13
- Publications
- 16
Are you this provider?
Claim Your Profile